Tandem Diabetes Care

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNDM and other ETFs, options, and stocks.

About TNDM

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi and t:slim X2 Insulin Pump. 

CEO
John F. Sheridan
CEOJohn F. Sheridan
Employees
2,500
Employees2,500
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2006
Founded2006
Employees
2,500
Employees2,500

TNDM Key Statistics

Market cap
1.40B
Market cap1.40B
Price-Earnings ratio
-28.06
Price-Earnings ratio-28.06
Dividend yield
—
Dividend yield—
Average volume
3.27M
Average volume3.27M
High today
$20.26
High today$20.26
Low today
$17.70
Low today$17.70
Open price
$19.00
Open price$19.00
Volume
4.40M
Volume4.40M
52 Week high
$29.65
52 Week high$29.65
52 Week low
$12.26
52 Week low$12.26

Stock Snapshot

Tandem Diabetes Care(TNDM) stock is priced at $20.07, giving the company a market capitalization of 1.4B. It carries a P/E multiple of -28.06.

On 2026-11-15, Tandem Diabetes Care(TNDM) stock traded between a low of $17.70 and a high of $20.26. Shares are currently priced at $20.07, which is +13.4% above the low and -0.9% below the high.

Tandem Diabetes Care(TNDM) shares are trading with a volume of 4.4M, against a daily average of 3.27M.

In the last year, Tandem Diabetes Care(TNDM) shares hit a 52-week high of $29.65 and a 52-week low of $12.26.

In the last year, Tandem Diabetes Care(TNDM) shares hit a 52-week high of $29.65 and a 52-week low of $12.26.

TNDM News

Benzinga 2d
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options - Benzinga

...

Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options - Benzinga
TipRanks 2d
Tandem Diabetes Care Receives FDA Clearance for Tandem Mobi

The latest update is out from Tandem Diabetes Care ( (TNDM) ). On November 12, 2026, Tandem Diabetes Care received 510(k) clearance from the U.S. Food and Drug...

Simply Wall St 3d
Is Tandem Diabetes Care Undervalued Following Its Mobi Pump Recall?

Why the Mobi recall is front and center for Tandem Diabetes Care Tandem Diabetes Care (TNDM) is under close watch after recalling about 81,000 Mobi insulin pum...

Is Tandem Diabetes Care Undervalued Following Its Mobi Pump Recall?

Analyst ratings

52%

of 25 ratings
Buy
52%
Hold
48%
Sell
0%

More TNDM News

Simply Wall St 4d
Earnings Update Might Change The Case For Investing In Tandem Diabetes Care

Tandem Diabetes Care reported third quarter 2026 sales of US$283.69 million, a narrower net loss of US$7.09 million, and reaffirmed full year revenue guidance o...

Earnings Update Might Change The Case For Investing In Tandem Diabetes Care

People also own

Based on the portfolios of people who own TNDM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.